Free Trial

Inozyme Pharma (INZY) Earnings Date, Estimates & Call Transcripts

Inozyme Pharma logo
$3.95 -0.04 (-1.00%)
Closing price 05/20/2025 04:00 PM Eastern
Extended Trading
$3.96 +0.00 (+0.13%)
As of 08:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inozyme Pharma Earnings Summary

Inozyme Pharma issued Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.44, which missed the consensus estimate of -$0.43 by $0.01. With a trailing EPS of -$1.69, Inozyme Pharma's earnings are expected to decrease next year, from ($1.59) to ($1.64) per share.

Upcoming Q2
Earnings Date
Aug. 5Before Market OpensEstimated
Consensus EPS
(May. 14)
-$0.43
Actual EPS
(May. 14)
-$0.44 Missed By -$0.01

Q1 2025 Earnings Resources

INZY Upcoming Earnings

Inozyme Pharma's next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules.

Get Inozyme Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inozyme Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

INZY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Inozyme Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.44-$0.43-$0.44
Q2 20252-$0.40-$0.34-$0.37
Q3 20252-$0.35-$0.25-$0.30
Q4 20252-$0.25-$0.25-$0.25
FY 2025 8 -$1.44 -$1.27 -$1.36
Q1 20261-$0.25-$0.25-$0.25
Q2 20261-$0.26-$0.26-$0.26
Q3 20261-$0.26-$0.26-$0.26
Q4 20261-$0.24-$0.24-$0.24

Inozyme Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2025
(Estimated)
--------
5/14/2025Q1 2025-$0.43-$0.44 -$0.01-$0.44--
11/5/2024--$0.44-$0.39+$0.05-$0.39--
8/6/2024--$0.37-$0.44 -$0.07-$0.44--
5/7/2024Q1 2024-$0.35-$0.38 -$0.03-$0.38--
3/12/2024Q4 2023-$0.31-$0.35 -$0.04-$0.35--
11/7/2023Q3 2023-$0.32-$0.29+$0.03-$0.29--
8/8/2023Q2 2023-$0.43-$0.35+$0.08-$0.35--

Inozyme Pharma Earnings - Frequently Asked Questions

Inozyme Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on INZY's earnings history.

In the previous quarter, Inozyme Pharma (NASDAQ:INZY) missed the analysts' consensus estimate of ($0.43) by $0.01 with a reported earnings per share (EPS) of ($0.44). Learn more on analysts' earnings estimate vs. INZY's actual earnings.

Inozyme Pharma (NASDAQ:INZY) has a recorded net income of -$71.17 million. INZY has generated -$1.69 earnings per share over the last four quarters.

Inozyme Pharma's earnings are expected to decrease from ($1.59) per share to ($1.64) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:INZY) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners